deltatrials
Completed PHASE4 INTERVENTIONAL 4-arm NCT04209933

Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies

Comparison of Efficacy of Bismuth Potassium Citrate, Pectin Bismuth Capsules, and Pectin Bismuth Granules in the Treatment of Helicobacter Pylori (Hp) First-line Quadruple Regimen: a Multicenter, Randomized, Prospective, Comparative Clinical Trial

Sponsor: Xijing Hospital of Digestive Diseases

Updated 7 times since 2020 Last updated: Apr 6, 2021 Started: May 25, 2020 Primary completion: Aug 1, 2020 Completion: Aug 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bismuth and Gastric Cancer and is currently completed. Xijing Hospital of Digestive Diseases leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2020 – ~Aug 2020 · 7 months · monthly snapshotNot Yet Recruiting~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshotRecruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotRecruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotRecruiting~May 2021 – ~Jul 2024 · 38 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. May 2021 — Jul 2024 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  4. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE4

  5. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

Show 2 earlier versions
  1. Aug 2020 — Sep 2020 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  2. Jan 2020 — Aug 2020 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Xijing Hospital of Digestive Diseases
Data source: Xijing Hospital of Digestive Diseases

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations